Alexandra MacLean joined TVM as a Principal in 2020. She has a broad background in business development investments in multiple therapeutic areas in the pharmaceutical and medical device industries. Most recently she was the Head of Licensing and Business Development at Imbrium Therapeutics. Prior to this experience, Alix held roles in the medical device industry with Plasma Surgical and Covidien. At Covidien, she worked on multiple M&A deals and venture investments to diversify the business. She began her career in the pharmaceutical industry at Merck & Co. in cardiovascular clinical development.
Alexandra (Alix) received a bachelor’s degree from McGill University and a medical degree from Columbia University. She completed her residency in general surgery at NYU Medical Center, fellowships in Trauma Surgery and Critical Care at the University of Miami Medical Center and vascular surgery at The Johns Hopkins Hospital. She also holds a MPhil from Cambridge University and a MBA from the Leeds School of Business at the University of Colorado, Boulder.